In re Bystolic Antitrust Litig., No. 20-cv-05735 (S.D.N.Y)

In re Bystolic Antitrust Litig., No. 20-cv-05735 (S.D.N.Y)

Case Details
Filed On: July 23, 2020
Class Period -

In the Bystolic case, Faruqi & Faruqi represents a proposed class of direct purchasers of Forest Laboratories’ (now AbbVie) blood pressure drug, Bystolic.  The complaint alleges that Forest entered into reverse payment agreements with several would-be generic com

In the Bystolic case, Faruqi & Faruqi represents a proposed class of direct purchasers of Forest Laboratories’ (now AbbVie) blood pressure drug, Bystolic.  The complaint alleges that Forest entered into reverse payment agreements with several would-be generic competitors to delay market entry of their generic Bystolic products.

Counsel
Joseph T. Lukens
jlukens@faruqilaw.com
Phone (215) 277-5770
Fax (215) 277-5771
Peter Kohn
pkohn@faruqilaw.com
Phone (215) 277-5770
Fax (215) 277-5771
Office
Pennsylvania
1617 JFK Boulevard, Suite 1550 Philadelphia Pennsylvania 19103
Phone (215) 277-5770
Fax (215) 277-5771

Our Offices

Our offices are nationwide. If you have any questions about a case or our firm, please contact us.
Send Us a Message
New York
685 Third Avenue 26th Floor
New York New York 10017
(877) 247-4292 / (212) 983-9330
(212) 983-9331
Los Angeles
1901 Avenue of the Stars Suite 1060
Los Angeles California 90067
(424) 256-2884
(424) 256-2885
Atlanta
3565 Piedmont Road NE Building Four, Suite 380
Atlanta Georgia 30305
(404) 847-0617
(404) 506-9534
Philadelphia
1617 JFK Boulevard, Suite 1550 Philadelphia
Pennsylvania 19103
(215) 277-5770
(215) 277-5771